
无数据
无数据
无数据
| CAS Number | 152121-30-7 |
| Catalog Number | AG007YOR(AGN-PC-0O4BXT) |
| Chemical Name | 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole |
| IUPAC Name | 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol |
| InChI | InChI=1S/C20H14FN3O/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(25)8-4-15/h1-12,25H,(H,23,24) |
| InChI Key | QHKYPYXTTXKZST-UHFFFAOYSA-N |
| MDL Number | MFCD00941964 |
| Molecular Formula | C20H14FN3O |
| Molecular Weight | 331.3431 |
| SMILES | c1cc(ccc1c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)O |
| UNII | PVX798P8GI |
| Synonyms | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,
phenol, 4-(4-(4-fluorophenyl)-5-(4-pyridinyl)-1h-imidazol-2-yl)-,
SB 202190,
SB-202190,
SB202190,
SB 202190,
152121-30-7,
SB202190,
SB-202190,
FHPI,
SB202190 (FHPI),
UNII-PVX798P8GI,
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole,
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole,
CHEBI:79090,
PVX798P8GI,
SB 202190, Immobilized,
C20H14FN3O,
InSolution™ SB 202190,
4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol,
Phenol, 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-,
MFCD00941964,
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole,
4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol,
4-[5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol,
4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol,
4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl)phenol,
SMR001230795,
Kinome_3708,
Tocris-1264,
AC1NS4QB,
BiomolKI_000051,
Lopac-S-7067,
biotinylated SB202190,
BiomolKI2_000057,
Lopac0_000173,
BMK1-F3,
BSPBio_001106,
KBioGR_000446,
KBioSS_000446,
MLS002153419,
MLS006010258,
SCHEMBL158854,
CHEMBL278041,
GTPL4307,
SCHEMBL1230814,
DTXSID7041120,
BDBM13531,
CHEBI:92952,
KBio2_000446,
KBio2_003014,
KBio2_005582,
KBio3_000831,
KBio3_000832,
AOB2557,
EX-A313,
SYN1073,
4o77,
ZX-AFC001670,
Bio1_000479,
Bio1_000968,
Bio1_001457,
Bio2_000393,
Bio2_000873,
HMS1362H07,
HMS1792H07,
HMS1990H07,
HMS2235B15,
HMS3229M22,
HMS3244I13,
HMS3244I14,
HMS3244J13,
HMS3260D07,
HMS3267J19,
HMS3371G22,
HMS3403H07,
HMS3654O15,
HMS3676C22,
BCP00675,
Tox21_500173,
ABP000229,
BDBM50044784,
BS0317,
CF-035,
GK2422,
IN1110,
IN1113,
RS0054,
s1077,
ZINC14951176,
ZINC89221712,
AKOS005146403,
AKOS026750414,
ACN-053035,
AN-5323,
CCG-100655,
CCG-204268,
CS-0141,
LP00173,
QC-9800,
IDI1_002148,
SMP2_000191,
NCGC00015962-01,
NCGC00015962-02,
NCGC00015962-03,
NCGC00015962-04,
NCGC00015962-05,
NCGC00015962-06,
NCGC00015962-07,
NCGC00015962-08,
NCGC00015962-09,
NCGC00015962-10,
NCGC00025089-01,
NCGC00025089-02,
NCGC00025089-03,
NCGC00025089-04,
NCGC00025089-05,
NCGC00025089-06,
NCGC00260858-01,
AK-51368,
AS-16228,
BC280328,
HY-10295,
SC-27980,
AJ-128486,
LS-186973,
LS-187615,
EU-0100173,
FT-0743934,
SW218110-2,
X7402,
EC-000.2317,
S 7067,
SB 202190, >=98% (HPLC),
SB 202190/SB-202190,
121S307,
SR-01000075720,
SR-01000597393,
J-513574,
J-690315,
SR-01000075720-1,
SR-01000597393-1,
BRD-K54330070-001-05-5,
BRD-K54330070-001-07-1,
4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol,
A3839/0163020,
SB202190, 152121-30-7,
4-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]-phenol,
4-[4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazol-2-yl]phenol,
4-[4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol,
FHPI|||4-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)phenol,
4-[4-(4-fluorophenyl)-5-(4-pyridyl)-4-imidazolin-2-ylidene]cyclohexa-2,5-dien-1-one,
2RE,
4-(4-(4-fluorophenyl)-5-(pyridin-4-yl)-1,3-dihydro-2H-imidazol-2-ylidene)cyclohexa-2,5-dien-1-one,
4-[4-(4-fluorophenyl)-5-(4-pyridyl)-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one,
4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one,
Taprenepag,
Oxindole 94,
D0EF7D,
D0VC0I,
cc-468,
NJNKPVPFGLGHPA-UHFFFAOYSA-N,
C20-H14-F-N3-O,
CID5353940,
A1632,
A10823,
A15255,
S-7701,
C090942,
SB 202190, 98% - 25MG 25mg,
4-[4-(4-Fluorophenyl)-5-(pyridin-4-yl)-2H-imidazol-2-yl]phenol,
phenol, 4-(4-(4-fluorophenyl)-5-(4-pyridinyl)-1h-imidazol-2-yl)-,
|
| Complexity | 415 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 331.112g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 331.35g/mol |
| Monoisotopic Mass | 331.112g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 61.8A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.7 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

